Article
A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer
2019-05-17
Abstract excerpt
Metastatic castration resistant prostate cancer (mCRPC) is one of the most common cancers with a poor prognosis. To improve prognostic models of mCRPC, the Dialogue for Reverse Engineering Assessments and Methods (DREAM) Consortium organized a crowdsourced competition known as the Prostate Cancer DREAM Challenge. In the competition, data from four phase III clinical trials were utilized. A total of 1600 patients’...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 32e2cf4a-fbff-51db-a9bc-a7918d69c53b
- DOI
- 10.12688/f1000research.8192.2
